Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001384101-21-000038
Filing Date
2021-03-04
Accepted
2021-03-04 17:05:58
Documents
1
Period of Report
2021-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161489554524867.html 4  
1 FORM 4 wf-form4_161489554524867.xml 4 3566
  Complete submission text file 0001384101-21-000038.txt   5013
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 338 MAIN STREET #26E SAN FRANCISCO CA 94105
Business Address
Kennedy Giulia C (Reporting) CIK: 0001769333 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36156 | Film No.: 21715140